Prescribing guidelines for ENT medications during pregnancy.
Publication/Presentation Date
8-1-2003
Abstract
Profound physiologic changes occur during pregnancy, and they can alter the pharmacodynamics of an administered drug. Almost 85% of women take at least one prescription medication during a pregnancy. Nearly every drug administered to a mother crosses the placenta, and fetal drug levels can reach 50 to 100% of maternal serum concentrations. Because many otolaryngologic conditions are associated with pregnancy, it is essential that otolaryngologists who care for gravid patients know which drugs are safe and avoid unnecessary prescriptions so that the best care can be delivered to the pregnant patient without harming her unborn child. In this article, we discuss the relative safety and efficacy of various types of drugs frequently prescribed for pregnant women by otolaryngologists.
Volume
82
Issue
8
First Page
565
Last Page
568
ISSN
0145-5613
Published In/Presented At
Ambro, B. T., Scheid, S. C., & Pribitkin, E. A. (2003). Prescribing guidelines for ENT medications during pregnancy. Ear, nose, & throat journal, 82(8), 565–568.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
14503092
Department(s)
Administration and Leadership
Document Type
Article